Kanbis®

Antiepileptic agent Indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome (DS) in 2-year old patients and older.

Therapeutic Area
Antiepileptic agent

Active Ingredient
Cannabidiol

Line
Neurosciences

Dosage forms:
Oral solution 100 mg/mL in bottles of 30 mL and y 100 mL

Download Leaflet Descargar